HOME >> BIOLOGY >> NEWS
Findings give insight into how colon cells transform into precancerous polyps

A key signaling pathway appears to be critical to the earliest transformation of normal colon cells into growths called polyps that may advance to colon tumors, Vanderbilt-Ingram Cancer Center scientists have reported.

The findings suggest that, someday, doctors might use drugs that interrupt this pathway to treat individuals who are found to have colon cells on the verge of this transformation. The goal would be to prevent polyps -- and thus colon cancer -- from ever developing.

"Clearly, were a long way from doing that, but the prospects are very exciting," said Dr. Robert J. Coffey, Ingram Professor of Cancer Research and professor of Medicine and Cell Biology. Coffeys laboratory, in collaboration with the laboratory of David Threadgill, Ph.D., reported their findings recently in the Proceedings of the National Academy of Sciences.

The signalling pathway involves the epidermal growth factor receptor and the "ligands" that bind to it. The receptor sits across the cell surface, much like a satellite dish. The ligand fits into the receptor to transmit signals into the cell that prompt its growth. Scientists are focused on this pathway as more is learned about how it is involved in cancer development and progression and as new drugs are developed to interrupt it.

The Vanderbilt work helps clarify contradictory findings reported more than a year ago by two different groups. One group observed a 90 percent reduction in polyp formation when they used an inhibitor of EGFr in Min mice, a strain that is genetically engineered to develop hundreds of colon polyps. The other group did a similar experiment with a similar drug and found no effect.

So the Vanderbilt researchers instead turned to genetics. They took advantage of a mouse called waved2 that has a naturally occurring mutation in the EGFr tyrosine kinase domain (the section beneath the cell surface) that results in a 90 percent reduction in EGFr activity. These
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-354-0936
Vanderbilt University Medical Center
19-Apr-2002


Page: 1 2

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings offer further understanding about growth and development in young male gymnasts
7. Findings in frog oocytes may help study of chromosome physiology
8. Findings aid understanding of neurodegenerative diseases
9. Findings show exceptional longevity runs in families
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... Mass. (PRWEB) , ... July 08, 2019 , ... ... the company’s footprint in the biotechnology hub of Cambridge, MA. This expansion strengthens ... primary market research , and sales force effectiveness consulting for ...
(Date:6/24/2019)... ANGELES (PRWEB) , ... June 24, 2019 , ... According ... day with one of the four most common STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") ... reported that gay and bisexual African American men accounted for the largest number ...
(Date:6/16/2019)... ... June 14, 2019 , ... Emtec, ... will deliver a joint presentation with Versiti’s CIO at the Healthcare Industry ... Rosen Shingle Creek Resort. , Versiti Vice President and Chief Information Officer, Lynne ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... ... announced IOPP will add 80 of its scientific journals to DeepDyve’s rental service ... content to DeepDyve’s continually expanding library of more than 20 million articles, sourced ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., ... industries, announced today that they will be receiving 3 awards at the 2019 CRO ... received 2 awards in the categories of overall Quality and Compatibility (Access to desired ...
Breaking Biology Technology:
Cached News: